Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!
SIGN IN REGISTER
  • No product(s) in your cart!

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • CLOSE
  • Clinical Trials / Drug Trials News From Medical News Today







    Rare diseases more common than we think

    1 November 2019, 3:00 pm
    New research sheds light on the real number of people living with rare diseases globally and calls for the prioritization of these conditions.


    Failed dementia drug gets a second chance

    24 October 2019, 4:00 pm
    Biotech company Biogen have announced that they will file for official approval of a new Alzheimer's drug, while results in clinical trials were uncertain.





    Cancer: Why drug testing needs to improve

    18 September 2019, 3:00 pm
    A new study finds that many new cancer drugs may not work in the way their developers think they do, which could have implications for their effectiveness.












    FDA Drugs RSS Feed

    MedWatch: The FDA Safety Information and Adverse Event Reporting Program

    24 January 2020, 8:51 pm
    MedWatch is made up of voluntary and mandatory reporting on prescription medicines, over-the-counter medicines, non-vaccine biologicals, medical devices, special nutritional products, cosmetics and non-prescription human drug products marketed without an approved application.

    Drug Trial Snapshot: AYVAKIT

    24 January 2020, 7:01 pm
    AYVAKIT is used to treat adult patients with gastrointestinal stromal tumor (GIST) whose disease: is caused by certain abnormal platelet-derived growth factor receptor alpha (PDGFRA) genes and, cannot be surgically removed or, has spread throughout the body (metastatic GIST).

    On Demand Webinar: Recent Revisions to the ANDA Prioritization MAPP – Jan. 2020

    24 January 2020, 5:58 pm
    The FDA offers priority review to abbreviated new drug applications (ANDAs) that may have meaningful impact on generic drug access. Priority review means that FDA gives an ANDA submission either (1) a shorter goal date, or (2) an expedited review. For an ANDA submission to be eligible for priority r


    What's New Related to Drugs

    24 January 2020, 4:13 pm
    Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.


    MCM-Related Guidance by Date

    24 January 2020, 3:17 pm
    Guidances and other information of special interest to MCM stakeholders, sponsors and applicants, listed by date

    Drug Trials Snapshots

    24 January 2020, 3:17 pm
    Drug Trials Snapshots: breaking down the what, how and why. Drug Trials Snapshots is part of an overall FDA effort to make demographic data more available and transparent. Drug Trials Snapshots provide consumers with information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.

    Newly Added Guidance Documents

    24 January 2020, 2:02 pm
    Guidance documents represent the FDA's current thinking on a particular subject. New guidance documents are listed here for three months.



    Novel Drug Approvals for 2018

    24 January 2020, 11:52 am
    Innovation drives progress. When it comes to innovation in the development of new drugs and therapeutic biological products, FDA’s Center for Drug Evaluation and Research (CDER) supports the pharmaceutical industry at every step of the process.

    New Drug Therapy Approvals 2019

    24 January 2020, 11:36 am
    Summary of FDA Center for Drug Evaluation and Research’s approvals of novel drug therapies along with approvals for biosimilars and other new approvals.

    Novel Drug Approvals for 2019

    24 January 2020, 11:30 am
    Innovation drives progress. When it comes to innovation in the development of new drugs and therapeutic biological products, FDA’s Center for Drug Evaluation and Research (CDER) supports the pharmaceutical industry at every step of the process.



    FDA Drug Safety Podcasts

    23 January 2020, 5:22 pm
    FDA Drug Safety Podcasts are produced by FDA's Center for Drug Evaluation and Research (CDER)




    Springer Medicine

    Valvular Heart Disease

    30 August 2019, 11:10 pm
    series:Cardiovascular Medicine

    This book provides up-to-date and user-friendly guidance on the evaluation, diagnosis, and treatment of heart and vascular disease. Chapters cover a broad range of issues related to valve disease, including rheumatic fever, aortic root dilatation, infective endocarditis, and heart disease in pregnancy. The physical examination of major valve lesions, imaging techniques, and choosing a balance ...


    Valvular Heart Disease

    30 August 2019, 11:10 pm
    series:Cardiovascular Medicine

    This book provides up-to-date and user-friendly guidance on the evaluation, diagnosis, and treatment of heart and vascular disease. Chapters cover a broad range of issues related to valve disease, including rheumatic fever, aortic root dilatation, infective endocarditis, and heart disease in pregnancy. The physical examination of major valve lesions, imaging techniques, and choosing a balance ...


    CT of the Heart

    2 April 2019, 11:15 pm
    series:Contemporary Medical Imaging

    This book is a comprehensive and richly-illustrated guide to cardiac CT, its current state, applications, and future directions. While the first edition of this text focused on what was then a novel instrument looking for application, this edition comes at a time where a wealth of guideline-driven, robust, and beneficial clinical applications have evolved that are enabled by an enormous and ...


    CT of the Heart

    2 April 2019, 11:15 pm
    series:Contemporary Medical Imaging

    This book is a comprehensive and richly-illustrated guide to cardiac CT, its current state, applications, and future directions. While the first edition of this text focused on what was then a novel instrument looking for application, this edition comes at a time where a wealth of guideline-driven, robust, and beneficial clinical applications have evolved that are enabled by an enormous and ...



    Heart Failure

    23 February 2017, 12:21 am
    A Comprehensive Guide to Pathophysiology and Clinical Care

    This book elucidates the etiology of heart failure (HF) to assist understanding in the clinical therapies available.  It explains these in light of the better understanding of the pathophysiology of HF, which has translated into dramatic improvements in patient outcome.The chapters detail the causes, diagnosis and treatment of HF, and recognize that having become the leading cause of ...


    Changes in the Brain

    27 November 2016, 12:26 am
    Impact on Daily Life

    This informative text details the many changes in everyday life as the result of injury, illness, or aging affecting the brain. Experts across brain-related fields trace mechanisms of conditions such as Parkinson’s disease, TBI, and dementia as they impact regions of the brain, and resulting cognitive, emotional, sensory, and motor impairments as they contribute to deficits in personal and ...




    Management of Heart Failure

    23 January 2016, 12:23 am
    Volume 2: Surgical

    This book has been conceived as a rapid but comprehensive review for practitioners of all persuasions involved in the management of patients with heart failure. Heart failure is a problem of epidemic proportions in all parts of the world. State of the art treatment may not be accessible to all, but simply creating an awareness of simple methods of diagnosis and treatment would assist in ...


    Practical Pediatric Cardiology

    8 November 2015, 12:07 am
    Case-Based Management of Potential Pitfalls

    This book is a collection of cases highlighting situations which can ensnare even the best cardiologist working with pediatric patients. Heart disease in children has a number of diagnostic traps for the unwary, and many of those involved in the specialty have been caught at one time or another. Although the cases contained within these pages illustrate the importance of taking a good history ...


    Practical Pediatric Cardiology

    5 November 2015, 12:17 am
    Case-Based Management of Potential Pitfalls

    This book is a collection of cases highlighting situations which can ensnare even the best cardiologist working with pediatric patients. Heart disease in children has a number of diagnostic traps for the unwary, and many of those involved in the specialty have been caught at one time or another. Although the cases contained within these pages illustrate the importance of taking a good history ...




    Coronary Artery Disease

    15 March 2015, 12:02 am
    series:Cardiovascular Medicine

    Coronary Artery Disease offers today's most up-to-date, user-friendly guidance on the evaluation, diagnosis, and medical and surgical treatment of this most important aspect of cardiovascular disease. The book provides comprehensive coverage of every aspect of coronary arterial medicine from cardiac signs and symptoms through imaging and the genetic basis for coronary disease to surgery, ...


    FDA Food RSS Feed

    Palmer Candy Company Announces Voluntary Recall of Sea Salt Caramel Hearts

    17 January 2020, 9:57 pm
    Palmer Candy Company (www.palmercandy.com), announced today a limited recall of Sea Salt Caramel Hearts that were only sold at Bomgaards Supply Inc. Store in the Midwest States. The voluntary recall, in cooperation with the U.S. Food and Drug Administration (FDA) due to abundance of caution of a possible peanut allergen contamination. People who have an allergy or severe sensitivity to peanuts run the risk of serious or life-threatening allergic reaction if they consume these products.










    The Double Cola Company Recalls Select Cases of Its Cherry Ski Product

    25 July 2019, 2:40 pm
    The Double Cola Company is recalling approximately 200 cases of its Cherry SKI product because they are incorrectly labeled. Only the Cherry SKI products with the new design are being recalled, which were delivered to the southern Illinois, Evansville, IN and Winchester, OH markets.


    Hail Merry Issues Voluntary Recall Due to Labeling Error

    25 July 2019, 12:10 am
    Hail Merry LLC, a plant-based snack food company, voluntarily recalls its Meyer Lemon Mini Miracle Tart Party Pack of 6 from the market due to a labeling error. The products contain cashews as listed on the "Ingredients" label, however the "Contains" allergen warning statement does not specifically identify "cashews."

    Slade Gorton Co. Inc. Issues Allergy Alert On Undeclared Milk

    25 July 2019, 12:05 am
    Slade Gorton, Boston, MA is recalling the following products because they may contain undeclared milk. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume these products.

    Product Recall By Wegmans Of Assorted Muffins 4 Pack

    25 July 2019, 12:00 am
    The assorted muffin four pack may include a banana nut muffin containing walnuts, an allergen not listed on the label. People who have an allergy or sensitivity to nuts should not consume this product.

    Allergy Alert Issued in Five Northern California Whole Foods Market Stores for Undeclared Walnuts in Pumpkin Drop Cookies

    24 July 2019, 11:35 pm
    Five Whole Foods Market stores in Northern California are voluntarily recalling frosted Pumpkin Drop cookies because the products contained tree nut allergens (walnuts) that were not listed on the product label. People who have an allergy or severe sensitivity to walnuts run the risk of serious or life-threatening allergic reactions if they consume these products.

    Daisy’s Bakery Inc. Issues Alert On Undeclared Milk In “Gourmet Concha”

    24 July 2019, 11:15 pm
    Daisy’s Bakery Inc. of Clifton, New Jersey is recalling 4 ounce packages of Gourmet Concha, because it may contain undeclared milk. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume these products.


    Kroger Stores Issue Allergy Alert on Dark Chocolate Products due to Undeclared Milk

    24 July 2019, 11:10 pm
    Kroger stores in Michigan are recalling select bulk dark chocolate products following the GKI Foods LLC recall of dark chocolate products due to an undeclared milk allergen.

    People who have an allergy or severe sensitivity to milk run the risk of a serious or life-threatening allergic reaction if they consume this product.

    Nestle USA Initiates Voluntary Recall of Hot Pockets® Four Cheese Pizza Snack Bites Due to Undeclared Allergens

    24 July 2019, 11:05 pm
    Nestlé USA has initiated a recall of Hot Pockets® Four Cheese Pizza Snack Bites due to misbranding and undeclared allergens. The product was donated to a charitable organization in Missouri and was not sold in retail. The product contain the known allergens egg, milk, soy, and wheat, which are not declared. People who have an allergy or severe sensitivity to eggs, milk, soy or wheat run the risk of serious or life-threatening allergic reaction if they consume this product.